Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas. According to GlobalData, Phase II drugs for Unspecified ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback